Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

GCMG vs CCAP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GCMG Captures Overall Composite Edge (49.4 HOLD vs 19.6 STRONG SELL), While CCAP Leads 3–2 on Growth & Valuation Pillars

GCMG Overall Winner 6-Pillar Tally: GCMG 2 – 3 CCAP (1 Tie) Matrix Metrics: GCMG 7 – 3 CCAP

As of Nov 16, 2026, GCM Grosvenor Inc. (GCMG) captures the overall head-to-head institutional edge over Crescent Capital BDC, Inc. (CCAP) on higher Unified Composite conviction (49.4/100 HOLD vs. 19.6/100 STRONG SELL) after splitting the core matrix 7–3 (led by Growth & Scale, Balance Sheet & Cash Flow), while CCAP wins 3–2 across the 6-pillar growth and valuation breakdown. GCMG trades at $13.21 (12.2x Forward P/E, 27.2% operating margin) versus CCAP at $10.08 (6.9x Forward P/E, 78.4% operating margin).

  • Growth vs. Quality Trade-Off: GCMG earns the overall head-to-head edge with a stronger Unified Composite Score (49.4/100 HOLD vs. CCAP 19.6/100 STRONG SELL) and 1.18β · 41% Vol risk profile, whereas CCAP leads top-line expansion (-15.5% YoY revenue growth, 0.89x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GCMG vs CCAP
GCMG NASDAQ Head-to-Head Winner
GCM Grosvenor Inc. Class A Common Stock
Investment Advice
$13.21
-2.15% 1D
Market Cap $826.9M
TTM Revenue $406M
Forward P/E 12.2x
Beta / 30D Vol 1.18β · 41% Vol
Unified Composite Score
49.4 / 100 HOLD
Tech 46.0 Fund 46.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.0 · SMA20: $12.88 · SMA50: $12.90
CCAP NASDAQ
Crescent Capital BDC, Inc. Common stock
Institutional Equity
$10.08
-0.49% 1D
Market Cap $373.2M
TTM Revenue $156M
Forward P/E 6.9x
Beta / 30D Vol 0.44β · 50% Vol
Unified Composite Score
19.6 / 100 STRONG SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 61
RSI-14: 61.3 · SMA20: $9.36 · SMA50: $9.42

6-Pillar Scorecard Institutional Category Breakdown (GCMG 2 – 3 CCAP)

Columns: Metric · GCMG · CCAP
1. Valuation Multiples CCAP
Forward P/E 12.2x 6.9x
Trailing P/E 25.5x 7.4x
PEG Ratio N/M 0.89x
EV / Revenue 2.0x 2.4x
2. Growth & Scale GCMG
Revenue Growth (YoY) +9.0% -15.5%
Earnings Growth (YoY) +4.1% -14.9%
TTM Revenue (USD) $406M $156M
Market Cap $826.9M $373.2M
3. Profitability & Quality CCAP
Gross Margin 45.7% 100.0%
Operating Margin 27.2% 78.4%
Net Profit Margin 8.0% -2.0%
Return on Equity (ROE) 195.7% -0.5%
4. Balance Sheet & Cash Flow GCMG
Cash Generation (TTM) $114M EBITDA N/A
Cash Flow Margin 27.9% EBITDA Mgn N/A
Net Cash / Leverage $0.54 Book/Sh · 195.7% ROE $19.10 Book/Sh · -0.5% ROE
Dividend Yield 3.55% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 25.3% (50th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CCAP
OpEx & R&D Intensity 18.5% of Rev ($75M) 21.6% of Rev ($34M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Asset Management Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GCMG (7) vs CCAP (3)
Institutional Metric GCMG CCAP Criterion Row Edge
Market Capitalization
Scale
$826.9M $373.2M Larger Scale GCMG
Trailing P/E Ratio
Valuation
25.5x 7.4x Lower Multiple CCAP
Forward P/E Ratio
Valuation
12.2x 6.9x Lower Multiple CCAP
Revenue Growth (YoY)
Growth
+9.0% -15.5% Higher Growth GCMG
Operating Margin (TTM)
Profitability
27.2% 78.4% Higher Margin CCAP
Net Profit Margin
Profitability
8.0% -2.0% Higher Margin GCMG
Return on Equity (ROE)
Capital Efficiency
195.7% -0.5% Higher ROE GCMG
52-Week Range Position
Momentum
70% ($9–$15) 25% ($8–$15) Stronger Trend GCMG
Beta / 30D Volatility
Risk Regime
1.18β · 41% Vol 0.44β · 50% Vol Lower Realized Risk GCMG
Unified Institutional Score
Composite Signal
49.4 / 100 (HOLD) 19.6 / 100 (STRONG SELL) Higher Composite GCMG
Trailing 12M Revenue (USD)
Operating Scale
$406M $156M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
45.7% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.0x EV/Rev 0.89x PEG · 2.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$114M EBITDA ($0.54 Book/Sh · 195.7% ROE) N/A ($19.10 Book/Sh · -0.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CCAP +8.08 pp
GCMG: +5.18% · CCAP: +13.26%
3M Horizon GCMG +3.55 pp
GCMG: -3.29% · CCAP: -6.84%
6M Horizon GCMG +31.69 pp
GCMG: +22.66% · CCAP: -9.03%
1Y Horizon GCMG +40.7 pp
GCMG: +14.87% · CCAP: -25.83%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GCMG vs CCAP. Trailing 12-month operating profitability (GCMG 27.2% vs CCAP 78.4%) and valuation multiples (GCMG 12.2x vs CCAP 6.9x Forward P/E) are benchmarked directly in Pillar 4 below.

GCMG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$406M
Gross Margin45.7%
Op. Margin27.2%
ROE / Fwd P/E195.7% · 12.2x
CCAP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$156M
Gross Margin100.0%
Op. Margin78.4%
ROE / Fwd P/E-0.5% · 6.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GCMG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 25.3%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GCMG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CCAP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CCAP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GCMG Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $826.9M market capitalization and 27.2% operating margin.
OpEx & R&D Reinvestment 18.5% of Rev ($75M)
90D Engineering Disclosures 0 Published
CCAP Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $373.2M market capitalization and 78.4% operating margin.
OpEx & R&D Reinvestment 21.6% of Rev ($34M)
90D Engineering Disclosures 0 Published

Investor FAQ GCMG vs CCAP Key Questions & Quantitative Answers

As of Nov 16, 2026, GCM Grosvenor Inc. (GCMG) captures the overall head-to-head institutional edge over Crescent Capital BDC, Inc. (CCAP) on higher Unified Composite conviction (49.4/100 HOLD vs. 19.6/100 STRONG SELL) after splitting the core matrix 7–3 (led by Growth & Scale, Balance Sheet & Cash Flow), while CCAP wins 3–2 across the 6-pillar growth and valuation breakdown. GCMG trades at $13.21 (12.2x Forward P/E, 27.2% operating margin) versus CCAP at $10.08 (6.9x Forward P/E, 78.4% operating margin). Growth vs. Quality Trade-Off: GCMG earns the overall head-to-head edge with a stronger Unified Composite Score (49.4/100 HOLD vs. CCAP 19.6/100 STRONG SELL) and 1.18β · 41% Vol risk profile, whereas CCAP leads top-line expansion (-15.5% YoY revenue growth, 0.89x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

GCMG leads the Growth & Scale pillar: GCMG posts +9.0% YoY revenue growth and +4.1% YoY earnings growth on $406M TTM revenue (45.7% gross margin, 27.2% operating margin), compared with CCAP at -15.5% YoY revenue growth and -14.9% YoY earnings growth on $156M TTM revenue (100.0% gross margin, 78.4% operating margin). On trailing 12-month operating scale, GCMG generates $406M in USD-normalized revenue versus $156M for CCAP. In operating R&D and SG&A reinvestment, GCMG deploys 18.5% of Rev ($75M) (0 90-day corporate R&D disclosures) versus 21.6% of Rev ($34M) (0 disclosures) for CCAP.

CCAP screens cheaper on headline valuation multiples. GCMG trades at 12.2x Forward P/E, 25.5x Trailing P/E, N/M PEG, and 2.0x EV/Revenue (27.9% EBITDA margin), whereas CCAP trades at 6.9x Forward P/E, 7.4x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GCMG (195.7% ROE) versus CCAP (-0.5% ROE) capital efficiency.

In options market volatility and institutional positioning, GCMG carries 25.3% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.18β · 41% Vol realized risk). By comparison, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 50% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.